Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.00%

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has an Asset Resilience Ratio of 0.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 000766 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥103.30K

≈ $15.12K USD Cash + Short-term Investments

Total Assets

CN¥4.74 Billion

≈ $694.21 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2025)

This chart shows how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's Asset Resilience Ratio has changed over time. See Tonghua Golden-Horse Pharmaceutical Indu (000766) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tonghua Golden-Horse Pharmaceutical Indu (000766) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥103.30K	0.0%
Total Liquid Assets	CN¥103.30K	0.00%

Asset Resilience Insights

Limited Liquidity: Tonghua Golden-Horse Pharmaceutical Industry Co Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (2002–2025)

The table below shows the annual Asset Resilience Ratio data for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.02%	CN¥1.07 Million ≈ $157.08K	CN¥4.48 Billion ≈ $655.09 Million	0.00pp
2024-12-31	0.02%	CN¥1.09 Million ≈ $159.29K	CN¥4.48 Billion ≈ $656.09 Million	+0.00pp
2023-12-31	0.02%	CN¥1.05 Million ≈ $153.44K	CN¥4.52 Billion ≈ $661.31 Million	+0.02pp
2022-12-31	0.00%	CN¥128.39K ≈ $18.79K	CN¥4.69 Billion ≈ $685.58 Million	0.00pp
2021-12-31	0.00%	CN¥180.33K ≈ $26.39K	CN¥4.64 Billion ≈ $679.09 Million	-1.86pp
2020-12-31	1.86%	CN¥92.63 Million ≈ $13.55 Million	CN¥4.98 Billion ≈ $728.92 Million	+1.71pp
2019-12-31	0.14%	CN¥6.80 Million ≈ $995.05K	CN¥4.70 Billion ≈ $687.47 Million	-0.15pp
2018-12-31	0.30%	CN¥17.80 Million ≈ $2.60 Million	CN¥5.96 Billion ≈ $871.88 Million	-4.29pp
2017-12-31	4.59%	CN¥262.80 Million ≈ $38.46 Million	CN¥5.73 Billion ≈ $838.02 Million	-0.34pp
2016-12-31	4.93%	CN¥261.50 Million ≈ $38.27 Million	CN¥5.30 Billion ≈ $776.07 Million	+4.55pp
2015-12-31	0.38%	CN¥15.90 Million ≈ $2.33 Million	CN¥4.16 Billion ≈ $608.11 Million	--
2014-12-31	0.00%	CN¥0.00 ≈ $0.00	CN¥1.29 Billion ≈ $188.12 Million	--
2003-12-31	0.01%	CN¥80.00K ≈ $11.71K	CN¥1.44 Billion ≈ $210.85 Million	-0.01pp
2002-12-31	0.01%	CN¥200.00K ≈ $29.27K	CN¥1.53 Billion ≈ $224.00 Million	--

pp = percentage points

About Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

SHE:000766 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.47 Billion

CN¥23.70 Billion CNY

Market Cap Rank

#4605 Global

#805 in China

Share Price

CN¥24.52

Change (1 day)

-2.35%

52-Week Range

CN¥18.46 - CN¥29.50

All Time High

CN¥29.50